Internal Medicine, Infectious Disease · Riverdale, GA
NPI
1548276603
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
7
Medicare group memberships
Hospitals
1
Hospital affiliations
6285 Garden Walk Blvd, Ste A
Riverdale, GA, 30274
Phone (770) 991-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
6,151 services
Medicare patients, 2024
187
Average age 72
Drug cost, 2024
$3.3M
1,530 prescriptions
Company payments, 2025
$625
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lee A Diamond was code 99233 (hospital e&m - subsequent), 264 times for 91 patients. In total Lee A Diamond billed 6,151 services in 35 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 264 | 91 | $91.93 | $24K |
| 99223 Hospital E&M - Initial | Facility | 66 | 63 | $129.60 | $8,554 |
| 99214 Office E&M - Established | Office | 64 | 43 | $77.64 | $4,969 |
| 99213 Office E&M - Established | Office | 57 | 31 | $68.16 | $3,885 |
| 99232 Hospital E&M - Subsequent | Facility | 55 | 20 | $61.35 | $3,374 |
| 99448 E&M - Miscellaneous | Facility | 53 | 31 | $41.88 | $2,220 |
| 99203 Office E&M - New | Office | 13 | 13 | $80.86 | $1,051 |
By year: 2022 $255K for 18,525 services; 2023 $121K for 8,688 services; 2024 $101K for 6,151 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lee A Diamond prescribed most often to Medicare patients was Genvoya (Elviteg/Cob/Emtri/Tenof Alafen), with 274 prescriptions and refills. In total Lee A Diamond wrote 1,530 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 274 | 284 | 27 | $1.1M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 270 | 270 | 36 | $1.1M |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 128 | 128 | 15 | $488K |
| Juluca Dolutegravir/Rilpivirine | 53 | 63 | Under 11 | $226K |
| Tivicay Dolutegravir Sodium | 35 | 35 | Under 11 | $84K |
| Descovy Emtricitabine/Tenofov Alafenam | 34 | 34 | Under 11 | $80K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 28 | 28 | Under 11 | $7,154 |
| Fluconazole Generic | 27 | 27 | Under 11 | $243 |
| Rosuvastatin Calcium Generic | 25 | 55 | Under 11 | $173 |
| Clonazepam Generic | 24 | 24 | Under 11 | $156 |
| Acyclovir Generic | 24 | 34 | Under 11 | $336 |
| Valacyclovir Valacyclovir Hcl | 23 | 33 | Under 11 | $681 |
| Ciprofloxacin Hcl Generic | 20 | 25 | 11 | $192 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 18 | 18 | Under 11 | $309 |
| Ceftriaxone Ceftriaxone Sodium | 17 | 17 | Under 11 | $1,424 |
Brand drugs: 871 claims; generic drugs: 659 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lee A Diamond $625 ($625 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $300.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.